Dr. Yentz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 East Medical Center Dr
B1 floor Cancer Recp D
Ann Arbor, MI 48109Phone+1 734-647-8903
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2012 - 2015
University of Michigan Medical SchoolClass of 2011
Certifications & Licensure
MI State Medical License 2015 - 2025
IL State Medical License 2011 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Publications & Presentations
PubMed
- 1 citationsA Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer.Irene Tsung, Edward Green, Phillip Palmbos, Zachery Sloan, Zachery R Reichert
The Journal of Urology. 2023-01-01 - 3 citationsTreatment related toxicities with combination BRAF and MEK inhibitor therapy in resected stage III melanoma.Morgan Homan, Govind Warrier, Christopher D Lao, Sarah Yentz, Shawna Kraft
Frontiers in Oncology. 2022-01-01 - 15 citationsPrognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer.Alex K Bryant, Kamya Sankar, Garth W Strohbehn, Lili Zhao, David Elliott
Lung Cancer. 2022-01-01
Journal Articles
- Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer ImmunotherapyDavid Smith, Sarah Yentz, Biodrugs
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
